Perfil
Virginie Carmignac founded Termino C 2436 AB in 2011.
Ms. Carmignac is also the founder of Merozyne Therapeutics AB.
Cargos activos de Virginie Carmignac
Empresas | Cargo | Inicio |
---|---|---|
Merozyne Therapeutics AB
Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Fundador | - |
Antiguos cargos conocidos de Virginie Carmignac.
Empresas | Cargo | Fin |
---|---|---|
Termino C 2436 AB
Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Merozyne Therapeutics AB
Merozyne Therapeutics AB Pharmaceuticals: MajorHealth Technology Merozyne Therapeutics AB develops and manufactures pharmaceutical products. The company was founded Madeleine Durbeej-Hjalt and Virginie Carmignac and is headquartered in Lund, Sweden. | Health Technology |
Termino C 2436 AB
Termino C 2436 AB Pharmaceuticals: MajorHealth Technology Termino C 243 AB is a holding company that develops therapy treatment for children with muscular disorder. It focuses on muscular dystrophy. The company was founded by Virginie Carmignac and Madeleine Durbeej-Hjalt in 2011 and is headquartered in Lund, Sweden. | Health Technology |
- Bolsa de valores
- Insiders
- Virginie Carmignac